These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 4623662)
1. Fluphenazine-induced parkinsonism in the baboon: pharmacological and metabolic studies. Dreyfuss J; Beer B; Devine DD; Roberts BF; Schreiber EC Neuropharmacology; 1972 Mar; 11(2):223-30. PubMed ID: 4623662 [No Abstract] [Full Text] [Related]
2. Excretion and biotransformation of the enanthate ester of fluphenazine- 14 C by the dog. Dreyfuss J; Ross JJ; Schreiber EC J Pharm Sci; 1971 Jun; 60(6):829-33. PubMed ID: 5128931 [No Abstract] [Full Text] [Related]
3. Comparison of amantadine, orphenadrine, and placebo in the control of phenothiazine-induced Parkinsonism. Mindham RH; Gaind R; Anstee BH; Rimmer L Psychol Med; 1972 Nov; 2(4):406-13. PubMed ID: 4571143 [No Abstract] [Full Text] [Related]
4. Neuroleptics and the corpus striatum: clinical implications. Stimmel GL Dis Nerv Syst; 1976 Apr; 37(4):219-24. PubMed ID: 1253676 [No Abstract] [Full Text] [Related]
5. Acute extrapyramidal reactions with fluphenazine hydrochloride and fluphenazine decanoate. Gelenberg AJ; Doller JC; Schooler NR; Mieske M; Severe J; Mandel MR Am J Psychiatry; 1979 Feb; 136(2):217-9. PubMed ID: 367182 [No Abstract] [Full Text] [Related]
7. Biological disposition and metabolic fate of fluphenazine- 14 C in the dog and rhesus monkey. Dreyfuss J; Ross JJ; Schreiber EC J Pharm Sci; 1971 Jun; 60(6):821-5. PubMed ID: 5001926 [No Abstract] [Full Text] [Related]
8. [The identification of fluphenazine in biological media. Initial results]. Viala A; Cano JP Ann Biol Clin (Paris); 1968; 26(5):693-709. PubMed ID: 5681858 [No Abstract] [Full Text] [Related]
9. Extrapyramidal symptoms in the course of fluphenazine treatment. Bastecký J; Vinar O; Taussigová D Act Nerv Super (Praha); 1972; 14(2):97-9. PubMed ID: 5040184 [No Abstract] [Full Text] [Related]
10. [Contribution to the study of the metabolism of fluphenazine in man]. Viala A; Cano JP; Philippe A Ann Pharm Fr; 1969; 27(7):511-8. PubMed ID: 5368589 [No Abstract] [Full Text] [Related]
11. Ethopropazine and benztropine in neuroleptic-induced parkinsonism. Chouinard G; Annable L; Ross-Chouinard A; Kropsky ML J Clin Psychiatry; 1979 Mar; 40(3):147-52. PubMed ID: 33969 [TBL] [Abstract][Full Text] [Related]
12. [Clinical experiences with a delayed-action preparation of fluphenazine]. Schwingenheuer J Arzneimittelforschung; 1972 Nov; 22(11):1918-21. PubMed ID: 4633589 [No Abstract] [Full Text] [Related]
13. Reactions to fluphenazine hydrochloride by two adult male macaques. Boelkins RC Lab Anim Sci; 1971 Apr; 21(2):272-4. PubMed ID: 4325707 [No Abstract] [Full Text] [Related]
14. Side effects of depot fluphenazines. Ayd FJ Compr Psychiatry; 1974; 15(4):277-84. PubMed ID: 4607070 [No Abstract] [Full Text] [Related]
15. Identification of 7-hydroxyfluphenazine as major metabolite of fluphenazine- 14 C in the dog. Dreyfuss J; Cohen AI J Pharm Sci; 1971 Jun; 60(6):826-8. PubMed ID: 5128930 [No Abstract] [Full Text] [Related]
16. Iatrogenic morbidity in patients taking depot fluphenazine. Jose C; Mallya A; Mehta D; Evenson R; Holland R Am J Psychiatry; 1979 Jul; 136(7):976-7. PubMed ID: 453363 [No Abstract] [Full Text] [Related]
17. A double-blind study of amantadine hydrochloride versus benztropine mesylate in drug-induced parkinsonism. Kelly JT; Zimmermann RL; Abuzzahab FS; Schiele BC Pharmacology; 1974; 12(2):65-73. PubMed ID: 4610599 [No Abstract] [Full Text] [Related]
18. Comparison of depot fluphenazines: duration of action and incidence of side effects. Donlon PT; Axelrad AD; Tupin JP; Chien C Compr Psychiatry; 1976; 17(2):369-76. PubMed ID: 1253596 [No Abstract] [Full Text] [Related]
19. Development and management of extrapyramidal symptoms in hypertensive patients treated with diazoxide. Pohl JE Am Heart J; 1975 Mar; 89(3):401-2. PubMed ID: 1114967 [No Abstract] [Full Text] [Related]